Procalcitonin metabolomics in the critically ill reveal relationships between inflammation intensity and energy utilization pathways
Abstract Procalcitonin is a biomarker of systemic inflammation and may have importance in the immune response. The metabolic response to elevated procalcitonin in critical illness is not known. The response to inflammation is vitally important to understanding metabolism alterations during extreme s...
Guardado en:
Autores principales: | Hirotada Kobayashi, Karin Amrein, Jessica A. Lasky-Su, Kenneth B. Christopher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/74b49f3ac1674f67bef69711dd30dbad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolomic differences between critically Ill women and men
por: Sowmya Chary, et al.
Publicado: (2021) -
Impact of a Procalcitonin-Based Protocol on Antibiotic Exposure and Costs in Critically Ill Patients
por: Jarva Chow, MD, MS, MPH, et al.
Publicado: (2021) -
Procalcitonin is not a marker of sterile inflammation in dogs after ovariohysterectomy
por: Gürbüz Hasan Oğuz, et al.
Publicado: (2017) -
Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS
por: Owen Richards, et al.
Publicado: (2021) -
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients
por: Douglas D. Fraser, MD, PhD, et al.
Publicado: (2020)